Key facts
- This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 03 Dec 2024, 17:28.
Mala Murthy - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- TDOC
- Reported as of
- 29 Nov 2024
- Net transaction value
- -$104,755
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2024, 17:28:10 UTC
- Prior SEC filing
- 04 Sep 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam C. Vandervoort, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Dec 2024.
Change
- Previous filing in this sequence was filed on 04 Sep 2024.
- Current net transaction value: -$104,755.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,641
- Change %
- +3.1%
- Price
- Shares after
- 88,408
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,369
- Change %
- +3.8%
- Price
- Shares after
- 91,777
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F2
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,044
- Change %
- +2.2%
- Price
- Shares after
- 93,821
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F2
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,750
- Change %
- +8.3%
- Price
- Shares after
- 101,571
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F2
TDOC
transaction
Common Stock
Sale
- Transaction value
- $104,755
- Shares
- -8,783
- Change %
- -8.6%
- Price
- $11.93
- Shares after
- 92,788
- Date
- 02 Dec 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TDOC
transaction
Derivative
Performance Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,641
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 13,208
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,641
- Exercise price
- Footnotes
- F1, F4
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,369
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 3,369
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,369
- Exercise price
- Footnotes
- F2, F5
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,044
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 4,088
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,044
- Exercise price
- Footnotes
- F2, F6
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,750
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 38,754
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,750
- Exercise price
- Footnotes
- F2, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F3
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
Footnote F4
On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F5
On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F6
On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F7
On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.